EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo

Lea S Stahl iD, Claudia Zeidler iD, Joyce Loewenthal iD, Svenja Royeck iD, Matthias Augustin iD, Robert Bissonnette iD, Sarina Elmariah iD, Brian S Kim iD, Laurent Misery iD, Hiroyuki Murota iD, Hong Liang Tey iD, Elke Weisshaar iD und 5 weitere

Journal of the European Academy of Dermatology and Venereology · 2026

DOI: 10.1111/jdv.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Lea S Stahl und 16 weiteren Autor:innen. Beteiligte Einrichtung: Section Pruritus Medicine, Department of Dermatology, and Center of Chronic Pruritus, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Prurigo, Algorithms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Galderma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To date, the management of chronic prurigo (CPG; prurigo nodularis) relies on expert consensus and guidelines without providing detailed recommendations on long‐term treatment management.

Objectives

This study was initiated by an expert committee to define, validate and reach consensus on treat‐to‐target (T2T) criteria and a decision‐supporting treatment algorithm for CPG.

Methods

A prospective, single‐centre, non‐interventional study was conducted in adult CPG patients at a moderate‐to‐severe disease stage, experiencing intense itch (NRS ≥7; Group A), and in patients who considered themselves successfully treated (Group B). The patients answered questions about their most severe symptoms and essential therapy goals. A committee of 14 field experts evaluated the study results, identified outcome tools from clinical trials and defined and weighted T2T criteria. Based on this, a treatment algorithm was developed through an iterative consensus‐building method and anonymous voting.

Results

171 patients (Group A, n = 96; Group B, n = 75) were interviewed. Itch (99.4%), the need to scratch (48%), and pruriginous lesions (45.6%) were the most frequently reported severe symptoms. Pruritus relief (over complete pruritus resolution) and healing of lesions were the key therapeutic goals. In clinical trials, the most frequently used instruments were assessments of worst/peak itch intensity, disease severity via IGA, DLQI and sleep quality. According to the results, the experts defined initial itch control as NRS ≤3, lesion healing with IGA‐S 0/1, and burden, along with their respective clinically measurable parameters, as T2T criteria. These criteria, with predefined cut‐off values, serve as the decision‐tree keys that constitute the treatment algorithm presented here, facilitating a decision to maintain or switch the treatment.

Conclusions

The T2T criteria and the SWITCH treatment algorithm offer a valid and systematic method for evaluating and refining CPG treatment based on patient‐reported and expert‐validated data. This will help to improve the treatment of patients with CPG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrurigoAlgorithmsHumansChronic DiseaseFemaleProspective StudiesPruritusMaleMiddle AgedAdultSeverity of Illness IndexAged

Stichwörter der Autor:innen

chronic prurigochronic pruritusitchprurigo nodularistreatment algorithmtreat‐to‐target

Autor:innen und Institutionen

  • Section Pruritus Medicine, Department of Dermatology, and Center of Chronic Pruritus, University Hospital Münster, Münster, Germany.
  • Competence Center of Healthcare Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Innovaderm Research, Montreal, Quebec, Canada.
  • Department of Dermatology, University of California, San Francisco, California, USA.
  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Laboratoire Interactions Neurones-Keratinocytes (LINK), University of Brest, Brest, France.

ORCID-Profile: Lea S Stahl, Claudia Zeidler, Joyce Loewenthal, Svenja Royeck, Matthias Augustin, Robert Bissonnette, Sarina Elmariah, Brian S Kim, Laurent Misery, Hiroyuki Murota, Hong Liang Tey, Elke Weisshaar, Gil Yosipovitch, Franz J Legat, Adam Reich, Martin Metz, Sonja Ständer

Förderung

  • Deutsche Forschungsgemeinschaft
  • Galderma

Zitieren

APA

Stahl, L. S., Zeidler, C., Loewenthal, J., Royeck, S., Augustin, M., Bissonnette, R., Elmariah, S., Kim, B. S., Misery, L., Murota, H., Tey, H. L., Weisshaar, E., Yosipovitch, G., Legat, F. J., Reich, A., Metz, M., & Ständer, S. (2026). The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70171

Vancouver

Stahl LS, Zeidler C, Loewenthal J, Royeck S, Augustin M, Bissonnette R, et al. The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70171

BibTeX
@article{Stahl2026,
  author = {Stahl, Lea S and Zeidler, Claudia and Loewenthal, Joyce and Royeck, Svenja and Augustin, Matthias and Bissonnette, Robert and Elmariah, Sarina and Kim, Brian S and Misery, Laurent and Murota, Hiroyuki and Tey, Hong Liang and Weisshaar, Elke and Yosipovitch, Gil and Legat, Franz J and Reich, Adam and Metz, Martin and Ständer, Sonja},
  title = {The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  doi = {10.1111/jdv.70171}
}
Kostenlos starten →